1.中国中医科学院广安门医院,北京市西城区北线阁5号,100053
2.中国医学科学院北京协和医院
doctorjq@126.com
收稿:2025-04-21,
修回:2025-07-20,
纸质出版:2025-11-02
移动端阅览
韩曼,姜泉,曾小峰等.基于“体脏合痹”理论探讨风湿免疫病中西医结合诊疗思维框架的构建[J].中医杂志,2025,66(21):2209-2215.
HAN Man,JIANG Quan,ZENG Xiaofeng,et al.Construction of an Traditional Chinese and Western Medicine Integrated Framework for Diagnosis and Treatment of Rheumatic and Immunological Diseases Based on the Theory of the Integration of Body and Viscera in Bi (痹) Disorders[J].Journal of Traditional Chinese Medicine,2025,66(21):2209-2215.
韩曼,姜泉,曾小峰等.基于“体脏合痹”理论探讨风湿免疫病中西医结合诊疗思维框架的构建[J].中医杂志,2025,66(21):2209-2215. DOI: 10.13288/j.11-2166/r.2025.21.006.
HAN Man,JIANG Quan,ZENG Xiaofeng,et al.Construction of an Traditional Chinese and Western Medicine Integrated Framework for Diagnosis and Treatment of Rheumatic and Immunological Diseases Based on the Theory of the Integration of Body and Viscera in Bi (痹) Disorders[J].Journal of Traditional Chinese Medicine,2025,66(21):2209-2215. DOI: 10.13288/j.11-2166/r.2025.21.006.
基于“体脏合痹”理论,构建风湿免疫病体-脏动态关联的诊疗思维框架。在阐释“体脏合痹”理论内涵的基础上,从免疫稳态和异常免疫反应两个方面对“体脏合痹”理论进行中西医学互释;提出“体脏合痹”理论指导下诊断思维、治疗思维、预防思维、康复思维的四维整合诊疗思维体系框架,并对该框架结合现代技术的发展前景进行展望,为风湿免疫病的中西医结合诊疗提供思路和方法。
Based on the theory of the integration of body and viscera in
Bi
(痹) disorders, this paper constructs a diagnostic and therapeutic framework emphasizing the dynamic interrelation between the body and internal organs in rheumatic and immunological diseases. On the foundation of elucidating the theoretical connotation of "integration of body and viscera in
Bi
disorders", the concept is interpreted through both traditional Chinese medicine (TCM) and modern biomedical perspectives, focusing on immune homeostasis and abnormal immune responses. Under this theoretical guidance, a four-dimensional integrative diagnostic and therapeutic thinking framework is proposed, encompassing diagnostic, therapeutic, preventive, and rehabilitative dimensions. Furthermore, this paper explores the prospects of combining this framework with modern medical technologies, aiming to provide new ideas and methodologies for the integrated TCM and western medical management of rheumatic and immunological diseases.
齐德生 . 中医风湿病发展史研究 [D]. 杭州 : 浙江中医药大学 , 2017 .
李振彬 . 关注风湿病的共存疾病(共病)研究 [C]//中国中西医结合学会风湿类疾病专业委员会. 第十六届中国中西医结合风湿病学术年会论文集 . 广州 : 中国人民解放军白求恩国际和平医院 , 2018 : 203 .
胡玉玺 , 何驰宇 , 高璇 , 等 . 风湿免疫疾病治疗药物的研究进展 [J]. 现代药物与临床 , 2020 , 35 ( 9 ): 1930 - 1936 .
姜泉 . “体脏合痹”理论内涵及其在风湿免疫病防治中的应用思路 [J]. 中医杂志 , 2024 , 65 ( 16 ): 1656 - 1661 .
AWUAH WA , HUANG H , KALMANOVICH J , et al . Circadian rhythm in systemic autoimmune conditions: potential of chrono-immunology in clinical practice: a narrative review [J]. Medicine (Baltimore) , 2023 , 102 ( 32 ): e34614 .
KUGELBERG E . Immune homeostasis: balancing the gut [J]. Nat Rev Immunol , 2013 , 13 ( 12 ): 848 - 849 .
LU Y , WANG Y , RUAN T , et al . Immunometabolism of Tregs: mechanisms, adaptability, and therapeutic implications in diseases [J]. Front Immunol , 2025 , 16 : 1536020 . doi: 10.3389/fimmu.2025.1536020 http://dx.doi.org/10.3389/fimmu.2025.1536020 .
尧忠柳 , 王莘智 , 叶新萍 , 等 . 从“正气化邪”探析自身免疫病的病机及辨治 [J]. 中医杂志 , 2024 , 65 ( 10 ): 1013 - 1018 .
XIAO F , RUI K , HAN M , et al . Artesunate suppresses Th17 response via inhibiting IRF4-mediated glycolysis and ameliorates Sjog̈ren's syndrome [J]. Signal Transduct Target Ther , 2022 , 7 ( 1 ): 274 .
朴雪梅 , 王亚乐 , 丁兴 , 等 . 益气清络方对类风湿关节炎患者miR-146a表达和Th17、Treg水平的影响 [J]. 上海中医药大学学报 , 2017 , 31 ( 6 ): 36 - 39 .
VASILEV VV , NOE R , DRAGON-DUREY MA , et al . Functional characterization of autoantibodies against complement component C3 in patients with lupus nephritis [J]. J Biol Chem , 2015 , 290 ( 42 ): 25343 - 25355 .
ESPÉLI M , SMITH KG , CLATWORTHY MR . FcγRIIB and autoimmunity [J]. Immunol Rev , 2016 , 269 ( 1 ): 194 - 211 .
徐祖森 , 蔡华华 . 系统性红斑狼疮患者血浆血小板活化因子水平及其与血浆脂质过氧化物水平关系的研究 [J]. 中国麻风皮肤病杂志 , 2005 , 21 ( 6 ): 429 - 430 .
CHEN CY , TUNG HY , TSENG YF , et al . Verbascoside and isoverbascoside ameliorate transforming growth factor β1-induced collagen expression by lung fibroblasts through Smad/non-Smad signaling pathways [J]. Life Sci , 2022 , 308 : 120950 . doi: 10.1016/j.lfs.2022.120950 http://dx.doi.org/10.1016/j.lfs.2022.120950 .
DENG AF , WANG FX , WANG SC , et al . Bone-organ axes: bidirectional crosstalk [J]. Mil Med Res , 2024 , 11 ( 1 ): 37 .
XIE K , CHE Q , CHEN J , et al . SLAMF7-expressing B cells as crucial mediators in the pathogenesis of rheumatoid arthritis-interstitial lung disease [J]. Int Immunopharmacol , 2025 , 152 : 114392 . doi: 10.1016/j.intimp.2025. 114392 http://dx.doi.org/10.1016/j.intimp.2025.114392 .
谢爽 , 高明利 . 以肺痹论治类风湿关节炎肺间质纤维化 [J]. 实用中医内科杂志 , 2012 , 26 ( 3 ): 59 - 60 .
杨秀玲 . 益气化痰活血法联合西医治疗对肺间质纤维化的氧化应激反应与炎症因子的影响研究 [J]. 中医药导报 , 2014 , 20 ( 12 ): 60 - 62 .
TACK LJ , TATSI C , STRATAKIS CA , et al . Effects of glucocorticoids on bone: what we can learn from pediatric endogenous Cushing's syndrome [J]. Horm Metab Res , 2016 , 48 ( 11 ): 764 - 770 .
ANGELI A , OSELLA G , REIMONDO G , et al . Glucocorticoid-induced osteoporosis: recent findings [J]. Ann Ital Med Int , 2000 , 15 ( 1 ): 47 - 55 .
LIMA A , BERNARDES M , AZEVEDO R , et al . Pharmacogenomics of methotrexate membrane transport pathway: can clinical response to methotrexate in rheumatoid arthritis be predicted? [J]. Int J Mol Sci , 2015 , 16 ( 6 ): 13760 - 13780 .
GELFAND JM , WAN J , ZHANG H , et al . Risk of liver disease in patients with psoriasis, psoriatic arthritis, and rheumatoid arthritis receiving methotrexate: a population-based study [J]. J Am Acad Dermatol , 2021 , 84 ( 6 ): 1636 - 1643 .
MA K , LI L , LIU C , et al . Efficacy and safety of various anti-rheumatic treatments for patients with rheumatoid arthritis: a network meta-analysis [J]. Arch Med Sci , 2019 , 15 ( 1 ): 33 - 54 .
GONG X , LIU WX , TANG XP , et al . Traditional Chinese medicine Qingrehuoxue treatment vs. the combination of methotrexate and hydroxychloroquine for active rheumatoid arthritis: a multicenter, double-blind, randomized controlled trial [J]. Front Pharmacol , 2021 , 12 : 679588 . doi: 10.3389/fphar.2021.679588 http://dx.doi.org/10.3389/fphar.2021.679588 .
吴德鸿 , 李正富 , 何兆春 , 等 . 范永升“三维一体”理论在系统性红斑狼疮治疗中的运用 [J]. 中华中医药杂志 , 2021 , 36 ( 10 ): 5930 - 5933 .
甘逸鸿 , 彭佳琪 , 黄硕 , 等 . 系统性红斑狼疮诊治的中医原创思维解析 [J]. 中华中医药杂志 , 2024 , 39 ( 2 ): 580 - 583 .
陈烨峰 , 赵宇杉 , 林佳瑾 , 等 . 基于伏邪致痹探讨痛风的中医治疗策略 [J]. 实用中医内科杂志 , 2025 , 39 ( 5 ): 111 - 113 .
GODBOLE S , SOLOMON JL , JOHNSON M , et al . Treating cardiovascular disease in the inflammatory setting of rheumatoid arthritis: an ongoing challenge [J]. Biomedicines , 2024 , 12 ( 7 ): 1608 .
JIAO J , RUSSELL IJ , WANG W , et al . Ba-Duan-Jin alleviates pain and fibromyalgia-related symptoms in patients with fibromyalgia: results of a randomised controlled trial [J]. Clin Exp Rheumatol , 2019 , 37 ( 6 ): 953 - 962 .
WOŚ I , TABARKIEWICZ J . Effect of interleukin-6, -17, -21, -22, and -23 and STAT3 on signal transduction pathways and their inhibition in autoimmune arthritis [J]. Immunol Res , 2021 , 69 ( 1 ): 26 - 42 .
BHAGWATKAR SS , HARJPAL P , ANKAR P . A case report of Sjögren's syndrome and rheumatoid arthritis: the role of physiotherapy in enhancing quality of life [J]. Cureus , 2024 , 16 ( 3 ): e55411 .
PIANTA A , CHIUMENTO G , RAMSDEN K , et al . Identification of novel, immunogenic HLA-DR-presented prevotella copri peptides in patients with rheumatoid arthritis [J]. Arthritis Rheumatol , 2021 , 73 ( 12 ): 2200 - 2205 .
FERRO M , CHARNECA S , DOURADO E , et al . Probiotic supplementation for rheumatoid arthritis: a promising adjuvant therapy in the gut microbiome era [J]. Front Pharmacol , 2021 , 12 : 711788 . doi: 10.3389/fphar.2021. 711788 http://dx.doi.org/10.3389/fphar.2021.711788 .
0
浏览量
0
下载量
3
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号